CVI Holdings’s Zosano Pharma Corporation ZSAN Stock Holding History

CVI Holdings’s Portfolio ZSAN Stock Details ZSAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,703	Closed	-$1.89M	–	66
2018 Q1	$1.89M	Buy	+10,703	New	+$3.58M	2.56%	10

Other funds holding ZSAN

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

LOAMU

Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return

CVI Holdings's ZSAN Position: Q2 2018 in Review

CVI Holdings sold out of Zosano Pharma Corporation (ZSAN) in Q2 2018, closing a stake of 10,703 shares — an estimated $1.89M sold.

CVI Holdings first reported a position in ZSAN in Q1 2018 and held it in 1 quarter. The position peaked at $1.89M in Q1 2018. 25 funds tracked by Wall St. Rank hold ZSAN as of Q2 2018.

CVI Holdings reported no remaining Zosano Pharma Corporation position as of Q2 2018 after selling out during the quarter.
CVI Holdings sold 10,703 Zosano Pharma Corporation shares in Q2 2018, an estimated $1.89M.
CVI Holdings first reported a position in Zosano Pharma Corporation in Q1 2018 and held it in 1 quarter.
CVI Holdings's Zosano Pharma Corporation position peaked at $1.89M in Q1 2018.
25 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2018.

Based on CVI Holdings's 13F filing for Q2 2018, filed 14 Aug 2018.